NOVENTRA PHARMA – TIRRETA 60 mg

Description

Intermediate alternative Twice per week
Advanced 30–40 units Twice per week
This is a transcription of the supplier’s advertisement, not a medically validated dosing guide.
Important points:
The advertisement does not clearly identify the individual active ingredients or their quantities.
Retatrutide is investigational and is not approved for routine weight-loss treatment.
The advertised combination and dosing schedule should not be assumed safe or clinically established.
The concentration and syringe-unit conversion require independent verification.
Do not use this advertised mixing or dosing schedule without assessment by a qualified medical professional.